Wow! Caught me nappin'! My questions are: Did Hydrapharm buy the IP? Or did they just license it to be able to market it? I wondered years ago if the rights to Anatabloc could be licensed to an overseas pharmaceutical company and then import the product.
More questions. What does this mean to us shareholders? Who managed this deal to Hydrapharm?
I sunk quite a bit of hard earned cash into Rock Creek, starting way back to the CigRx days. I would like to recoup a least some of my money.